share_log

LENZ Therapeutics Q4 2024 GAAP EPS $(0.46) Misses $(0.41) Estimate

Benzinga ·  Mar 19 20:08

LENZ Therapeutics (NASDAQ:LENZ) reported quarterly losses of $(0.46) per share which missed the analyst consensus estimate of $(0.41) by 12.2 percent.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 350
Write a comment